Scientists design mouse with more human-like immune response

Date:

February 4, 2013

Source:

University of Southern California, Keck School of Medicine

Summary:

Scientists have genetically engineered a mouse to more closely mimic a human immune response. The transgenic mouse exhibits humanized CD1d molecules, naturally occurring molecules that activate an especially potent white blood cell called the natural killer T cell. The mouse model has the potential to accelerate development of human immunotherapies for diseases like cancer, diabetes and tuberculosis.

Share:

Total shares:

FULL STORY

Medical scientists at USC have bred a first-of-its-kind mouse model that possesses an immune response system more like that of a human's. The discovery makes way for quicker and more cost-effective development of next-generation drugs to treat human diseases, such as cancer, diabetes and tuberculosis.

Medical researchers have long used mice and rats to help formulate new drugs and vaccines, in part because their genetic and biological characteristics closely parallel human physiology. But many experimental drugs that work extraordinarily well in rodents fail miserably when tested in people.

One such drug, α-galactosylceramide (α-GalCer), essentially wipes out cancerous tumors in mice by activating the body's immune system; for reasons not entirely clear, the drug does not trigger the same response in people with cancer. Scientists hypothesize that this failure is due to subtle differences between the CD1d molecules in mice and humans and how they respond to tumors and infection. CD1d molecules are found on certain cells that trigger the body's innate immune response.

In a study to be published this week by the Proceedings of the National Academy of Sciences, USC researchers describe how they genetically engineered mice to express CD1d molecules that look more like those in humans and in more similar proportions. More importantly, the humanized CD1d molecules effectively trigger natural killer T (NKT) cells -- a recently discovered type of white blood cell that attacks tumors and infection -- in live animals when exposed to α-GalCer.

"It's the best model we have in the field," said Weiming Yuan, assistant professor of molecular microbiology and immunology at the Keck School of Medicine of USC and principal investigator of the study. "We've basically set a platform to fast-track the identification of immunotherapies that can kill cancer and also make vaccines stronger."

Once activated, NKT cells react in a matter of hours whereas other T cells may take days. This rapid response makes them difficult to study but also an ideal target for drug-makers. Yuan's humanized mouse allows scientists to more accurately test the viability of those NKT cell-targeting drugs before going to human clinical trials.

"Before, it would have been a guess as to whether the drug would work in people. Now, the chance of success goes from one out of 100 to one out of five," Yuan said.

Yuan and colleagues have yet to demonstrate the effects of inserting a more human-like version of the final component of the CD1d/NKT system, the T cell receptor. More experiments are necessary to determine why α-GalCer is ineffective in treating people with cancer and to develop novel α-GalCer derivatives that work with the human immune system.

Co-authors included Xiangshu Wen, Seil Kim and Agnieszka Lawrenczyk of the Keck School; Ping Rao of the UCLA Immunogenetics Center and Department of Pathology; Leandro Carreño and Steven Porcelli of the Albert Einstein College of Medicine at Yeshiva University; and Peter Cresswell of the Yale University School of Medicine.

The research was supported by the National Institutes of Health (R01 AI091987, R01 AI059167, R01 AI045889), the Harry Lloyd Charitable Trust, the Margaret Early Medical Research Trust and the Howard Hughes Medical Institute.

University of Southern California, Keck School of Medicine. "Scientists design mouse with more human-like immune response." ScienceDaily. ScienceDaily, 4 February 2013. <www.sciencedaily.com/releases/2013/02/130204153708.htm>.

University of Southern California, Keck School of Medicine. (2013, February 4). Scientists design mouse with more human-like immune response. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2013/02/130204153708.htm

University of Southern California, Keck School of Medicine. "Scientists design mouse with more human-like immune response." ScienceDaily. www.sciencedaily.com/releases/2013/02/130204153708.htm (accessed August 2, 2015).

July 31, 2015  Resettlement projects in the Amazon are driving severe tropical deforestation, according to new research. Widely hailed as a socially responsible and 'innocuous' strategy of land redistribution, ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

July 31, 2015  A new study examines how consuming the concentrated extract of thylakoids found in spinach can reduce hunger and cravings. Thylakoids encourage the release of satiety hormones, which is very ... read more

July 30, 2015  The behavior of fruit flies, which are commonly used in laboratory experiments, is altered by electric fields, new research shows. The research indicates that the wings of the insects are disturbed ... read more

July 31, 2015  Starvation early in life can alter an organism for generations to come, according to a new study in nematodes. The epigenetic effects are a 'bet-hedging strategy.' Famine survivors are smaller and ... read more

July 31, 2015  The humble butterfly could hold the key to unlocking new techniques to make solar energy cheaper and more efficient, pioneering new research has shown. By mimicking the v-shaped posture adopted by ... read more

Apr. 23, 2015  New model XactMice, uses human blood stem cells to grow a 'humanized' mouse immune system prior to tumor transplantation, allowing anti-cancer therapies to be tested in a much more ... read more

Jan. 2, 2014  Biologists have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now limiting the ... read more

July 28, 2012  Researchers have identified a new type of white blood cell which activates a killing immune response to an external source -- providing a new potential target for vaccines for conditions such as ... read more

Sep. 7, 2011  Like humans, mice that live in their natural habitat encounter bacteria and other pathogens that exercise their immune system, yet lab mice typically used in immunology studies are raised in ... read more